Rendez-vous
logo doc Documentation / Neurologie /

Démences (vasculaire et Alzheimer)

Alzheimer Disease as a Vascular Disorder

Insulin Signaling in Alzheimer’s Disease : Association with Brain Insulin Resistance

Older adults at greater risk for Alzheimer’s disease show stronger associations between sleep apnea severity in REM sleep and verbal memory

Incidence of Dementia and Alzheimer Disease in 2 Communities

Cerebral Cysticercosis Presenting as Progressive Dementia

Extracranial Vascular Arterial Stiffness Contributes to Cerebral Small Vessel Disease, Stroke, and Late-Onset Alzheimer’s Disease

Exercise Intervention for Alzheimer’s Disease: Unraveling Neurobiological Mechanisms and Assessing Effects

Impact of Mouthwash-Induced Oral Microbiome Disruption on Alzheimer’s Disease Risk

Multidomain therapy for Alzheimer’s disease

Sustained Cognitive Improvement in Alzheimer’s Disease Patients Following a Precision Medicine Protocol

Basic Mechanisms of Brain Injury and Cognitive Decline in Hypertension

Hypertension and Dementia

Capillary Dysfunction : Its Detection and Causative Role in Dementias and Stroke

Current updates on latest basic research of scientific relevance in hypertensive dementia

Impact of Sleep Disorders and Disturbed Sleep on Brain Health

Microbiota–gut–brain axis in neurodegenerative diseases

The role of gut microbiota in pathogenesis of Alzheimer Disease

Functional amyloid – from bacteria to humans



Assessing the Relationship Between the Flicker Test and Cognitive Performance

Critical Flicker Fusion Predicts Executive Function in Younger and Older Adults

Critical Flicker Fusion Threshold in patients with Alzheimer’s disease and vascular dementia

Critical Flicker Fusion Threshold : A Potentially Useful Measure for the Early Detection of Alzheimer’s Disease

The speed of sight : Individual variation in critical flicker fusion thresholds


IODE – VITAMINES


Iodine Deficiency and the Brain : Effects and Mechanisms

Vitamin deficiencies and Alzheimer’s disease

Association of Circulating Vitamin D in Midlife With Increased Tau-PET Burden in Dementia-Free Adults

Association of vitamin D with risk of dementia

Vitamin D and the risk of dementia and Alzheimer disease

Biometals in Alzheimer disease- emerging therapeutic and diagnostic potential of molybdenum and iodine

Thyroid dysfunction and Alzheimer’s disease, a vicious circle

The Association Between Thyroid Diseases and Alzheimer’s Disease in a National Health Screening Cohort in Korea

Thyroid Dysfunction and Risk of Parkinson’s Disease


THERAPEUTIQUE


Non Pharmaceutical Interventions for Alzheimers Disease The Role of Diet Exercise and Sleep in Slowing Disease Progression

Rapid improvement in Alzheimer’s disease symptoms following fecal microbiota transplantation

Dimethyl Sulfoxide Induces Both Direct and Indirect Tau Hyperphosphorylation

DMSO Delays Alzheimer Disease Causing Aβ-induced Paralysis in C. elegans Through Modulation of Glutamate:Acetylcholine Neurotransmission

Exercise-regulated bone–brain axis: A novel perspective on age-related cognitive decline

Exercise Intervention Associated with Cognitive Improvement in Alzheimer’s Disease

Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI

Reversal of cognitive decline : a novel therapeutic program

Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration

Psilocybin for the treatment of Alzheimer’s disease

Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to Neurodegeneration

Docteur Paul WULLEMAN
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.